Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

30.15
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
29.35
Today|||52-Week Range
58.95
-33.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues72.9M69.3M70.9M67.3M
 
 
 
 
 
Cost of Goods Sold20.4M21.5M20.1M14.9M
 
 
 
 
 
Depreciation And Amortization3.3M3.1M3.7M3.4M
 
 
 
 
 
 
Operating ExpensesGross Income49.3M44.7M47.1M49.1M
 
 
 
 
 
General Expenses51.7M58.8M58.4M52.4M
 
 
 
 
 
Research And Development17.1M16.6M18.9M11.8M
 
 
 
 
 
Total Operating Expenses75.4M83.3M82.2M70.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.5M-14.1M-11.3M-3.3M
 
 
 
 
 
Extraordinary Charge0.00-3.7M-4.5M-260.0K
 
 
 
 
Interest Expense On Debt2.1M2.8M5.4M5.4M
 
 
 
 
 
Other Expenses-75.0K10.0K80.0K79.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.0M-19.8M-19.7M-7.6M
 
 
 
 
 
Income Taxes-21.0K-30.0K-30.0K-45.0K
 
 
 
 
 
Net Income-4.0M-19.9M-19.7M-7.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.4M38.0M40.2M40.5M
 
 
 
 
 
Shares To Calculate EPS Diluted37.4M38.0M40.2M40.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.52-$0.49-$0.19
 
 
 
 
 
EPS Diluted-$0.11-$0.52-$0.49-$0.19